Medovate expands SAFIRA product range with further CE Mark approvals
Medovate has successfully secured additional CE Mark approvals for its SAFIRA (SAFer Injection for Regional Anaesthesia) technology to include an NRFit syringe and a Palm Operator
If you are not happy with the results below please do another search
Medovate has successfully secured additional CE Mark approvals for its SAFIRA (SAFer Injection for Regional Anaesthesia) technology to include an NRFit syringe and a Palm Operator